NCT01769885View on ClinicalTrials.gov

Tivozanib Before Surgery in Treating Patients With Localized Kidney Cancer

NAWithdrawnINTERVENTIONAL
0
Timeline

Start Date

March 14, 2013

Primary Completion Date

June 14, 2013

Study Completion Date

December 2, 2013

Conditions
Stage II Renal Cell CancerStage III Renal Cell Cancer
Interventions
DRUG

tivozanib

Given PO

PROCEDURE

therapeutic conventional surgery

Undergo nephrectomy

Sponsors
All Listed Sponsors
collaborator

AVEO Pharmaceuticals, Inc.

INDUSTRY

lead

Roswell Park Cancer Institute

OTHER